EP 1301624 A2 20030416 - PREPROCALCITONIN AS TUMOR REJECTION ANTIGEN PRECURSOR AND USES THEREOF
Title (en)
PREPROCALCITONIN AS TUMOR REJECTION ANTIGEN PRECURSOR AND USES THEREOF
Title (de)
PREPROCALCITONIN ALS TUMORABSTOSSUNGSANTIGENVORLÄUFER UND VERWENDUNGEN DAVON
Title (fr)
PREPROCALCITONINE UTILISEE COMME PRECURSEUR D'ANTIGENE DE REJET TUMORAL ET SES UTILISATIONS
Publication
Application
Priority
- US 0140288 W 20010314
- US 53956700 A 20000331
Abstract (en)
[origin: WO0175179A2] The invention relates to the identification of a tumor rejection antigen precursor. It has been established that preprocalcitonin protein functions as a tumor rejection antigen precursor, and is processed to at least one tumor rejection antigen. Complexes of the tumor rejection antigen and an MHC molecule are recognized by cytolytic T lymphocytes, and lysed.
IPC 1-7
IPC 8 full level
C07K 14/585 (2006.01); C12Q 1/68 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
C07K 14/585 (2013.01); C12Q 1/6886 (2013.01); A61K 38/00 (2013.01); C12Q 2600/158 (2013.01)
Citation (search report)
See references of WO 0175179A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0175179 A2 20011011; WO 0175179 A3 20030206; AU 5385201 A 20011015; EP 1301624 A2 20030416
DOCDB simple family (application)
US 0140288 W 20010314; AU 5385201 A 20010314; EP 01927400 A 20010314